Afya Net Worth
Afya Net Worth Breakdown | AFYA |
Afya Net Worth Analysis
Afya's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Afya's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Afya's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Afya's net worth analysis. One common approach is to calculate Afya's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Afya's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Afya's net worth. This approach calculates the present value of Afya's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Afya's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Afya's net worth. This involves comparing Afya's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Afya's net worth relative to its peers.
Enterprise Value |
|
To determine if Afya is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Afya's net worth research are outlined below:
| Afya is unlikely to experience financial distress in the next 2 years | |
| Afya has a strong financial position based on the latest SEC filings | |
| About 77.0% of the company shares are held by company insiders | |
| Latest headline from zacks.com: Company News for Mar 17, 2025 |
Afya uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Afya. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Afya's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 27th of March 2024 Upcoming Quarterly Report | View | |
| 22nd of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 27th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Afya Target Price Consensus
Afya target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Afya's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 9 | Buy |
Most Afya analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Afya stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Afya, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationAfya Target Price Projection
Afya's current and average target prices are 17.93 and 19.99, respectively. The current price of Afya is the price at which Afya is currently trading. On the other hand, Afya's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Target Price
Analyst Consensus On Afya Target Price
Know Afya's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Afya is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Afya backward and forwards among themselves. Afya's institutional investor refers to the entity that pools money to purchase Afya's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | |||
| Fidelity International Ltd | 2024-12-31 | 84.5 K | |
| D. E. Shaw & Co Lp | 2024-12-31 | 82.8 K | |
| Two Sigma Advisers, Llc | 2024-12-31 | 78.6 K | |
| Ubs O'connor Llc | 2024-12-31 | 77.8 K | |
| State Street Corp | 2024-12-31 | 77 K | |
| Two Sigma Investments Llc | 2024-12-31 | 72.1 K | |
| Bank Of America Corp | 2024-12-31 | 71.1 K | |
| Envestnet Asset Management Inc | 2024-12-31 | 66.8 K | |
| Jane Street Group Llc | 2024-12-31 | 56.3 K | |
| Ubs Group Ag | 2024-12-31 | 4.5 M | |
| Fmr Inc | 2024-12-31 | 2.9 M |
Follow Afya's market capitalization trends
The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.62 B.Market Cap |
|
Project Afya's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.19 | 0.22 | |
| Return On Capital Employed | 0.13 | 0.23 | |
| Return On Assets | 0.07 | 0.12 | |
| Return On Equity | 0.15 | 0.24 |
When accessing Afya's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Afya's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Afya's profitability and make more informed investment decisions.
Please note, the presentation of Afya's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Afya's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Afya's management manipulating its earnings.
Evaluate Afya's management efficiency
Afya has return on total asset (ROA) of 0.0772 % which means that it generated a profit of $0.0772 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1632 %, meaning that it created $0.1632 on every $100 dollars invested by stockholders. Afya's management efficiency ratios could be used to measure how well Afya manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to 0.22. The current year's Return On Capital Employed is expected to grow to 0.23. At present, Afya's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to about 282.9 M, whereas Total Assets are forecasted to decline to about 4.7 B.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 47.30 | 49.67 | |
| Tangible Book Value Per Share | (13.41) | (12.74) | |
| Enterprise Value Over EBITDA | 9.20 | 8.74 | |
| Price Book Value Ratio | 2.10 | 1.99 | |
| Enterprise Value Multiple | 9.20 | 8.74 | |
| Price Fair Value | 2.10 | 1.99 | |
| Enterprise Value | 11.2 B | 7.7 B |
The strategic vision of Afya management plays a critical role in its financial performance. By evaluating this vision, we provide insights into the stock's growth potential.
Enterprise Value Revenue 3.4753 | Revenue | Quarterly Revenue Growth 0.163 | Revenue Per Share | Return On Equity |
Afya Corporate Filings
6K | 13th of March 2025 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
| 4th of March 2025 Other Reports | ViewVerify | |
| 14th of February 2025 Other Reports | ViewVerify | |
| 14th of November 2024 Other Reports | ViewVerify |
Afya Earnings Estimation Breakdown
The calculation of Afya's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Afya is estimated to be 2.8672 with the future projection ranging from a low of 2.8672 to a high of 2.8672. Please be aware that this consensus of annual earnings estimates for Afya is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
2.87 Lowest | Expected EPS | 2.87 Highest |
Afya Earnings Projection Consensus
Suppose the current estimates of Afya's value are higher than the current market price of the Afya stock. In this case, investors may conclude that Afya is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Afya's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of March 2025 | Current EPS (TTM) | |
| 9 | 89.74% | 2.1 | 2.8672 | 1.22 |
Afya Earnings History
Earnings estimate consensus by Afya analysts from Wall Street is used by the market to judge Afya's stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Afya's upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.Afya Quarterly Gross Profit |
|
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Afya's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Afya Earnings per Share Projection vs Actual
Actual Earning per Share of Afya refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Afya predict the company's earnings will be in the future. The higher the earnings per share of Afya, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Afya Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Afya, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Afya should always be considered in relation to other companies to make a more educated investment decision.Afya Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Afya's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-12-31 | 2024-12-31 | 1.8119 | 2.1 | 0.2881 | 15 | ||
2024-11-14 | 2024-09-30 | 1.8298 | 1.79 | -0.0398 | 2 | ||
2024-08-14 | 2024-06-30 | 1.95 | 2.29 | 0.34 | 17 | ||
2024-05-09 | 2024-03-31 | 2.35 | 2.74 | 0.39 | 16 | ||
2024-03-14 | 2023-12-31 | 1.55 | 1.79 | 0.24 | 15 | ||
2023-11-13 | 2023-09-30 | 1.36 | 1.38 | 0.02 | 1 | ||
2023-08-28 | 2023-06-30 | 1.41 | 1.42 | 0.01 | 0 | ||
2023-05-24 | 2023-03-31 | 2.03 | 1.8 | -0.23 | 11 | ||
2023-03-22 | 2022-12-31 | 1.37 | 1.38 | 0.01 | 0 | ||
2022-11-21 | 2022-09-30 | 1.38 | 1.28 | -0.1 | 7 | ||
2022-08-22 | 2022-06-30 | 0.98 | 1.12 | 0.14 | 14 | ||
2022-05-23 | 2022-03-31 | 1.51 | 1.83 | 0.32 | 21 | ||
2022-03-31 | 2021-12-31 | 0.86 | 1.05 | 0.19 | 22 | ||
2021-11-22 | 2021-09-30 | 1.25 | 1.19 | -0.06 | 4 | ||
2021-08-26 | 2021-06-30 | 0.96 | 0.64 | -0.32 | 33 | ||
2021-04-08 | 2021-03-31 | 1.58 | 0.89 | -0.69 | 43 | ||
2020-12-31 | 2020-12-31 | 0.31 | 0.18 | -0.13 | 41 | ||
2020-12-03 | 2020-09-30 | 1.19 | 1.07 | -0.12 | 10 | ||
2020-08-27 | 2020-06-30 | 0.67 | 0.89 | 0.22 | 32 | ||
2020-05-28 | 2020-03-31 | 1.12 | 1.39 | 0.27 | 24 | ||
2020-03-26 | 2019-12-31 | 1.02 | 1.11 | 0.09 | 8 | ||
2019-12-02 | 2019-09-30 | 0.59 | 0.78 | 0.19 | 32 | ||
2019-08-30 | 2019-06-30 | 0.63 | 10.41 | 9.78 | 1552 |
Afya Corporate Management
| Julio Angeli | Vice Innovation | Profile | |
| Virgilio Gibbon | Chief Officer | Profile | |
| Luis Blanco | Chief Officer | Profile | |
| Renata Couto | Investor Manager | Profile |
Already Invested in Afya?
The danger of trading Afya is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Afya is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Afya. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Afya is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Afya offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Afya's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Afya Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Afya Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Afya. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. For information on how to trade Afya Stock refer to our How to Trade Afya Stock guide.You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Diversified Consumer Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Afya. If investors know Afya will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Afya listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.513 | Earnings Share 1.22 | Revenue Per Share | Quarterly Revenue Growth 0.163 | Return On Assets |
The market value of Afya is measured differently than its book value, which is the value of Afya that is recorded on the company's balance sheet. Investors also form their own opinion of Afya's value that differs from its market value or its book value, called intrinsic value, which is Afya's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Afya's market value can be influenced by many factors that don't directly affect Afya's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Afya's value and its price as these two are different measures arrived at by different means. Investors typically determine if Afya is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Afya's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.